title: Reply to the letter by Pan Yanna et al. 'treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies'.
authors.affiliation: Division of Nephrology, Maggiore Hospital and IRCCS Foundation, Milano, Italy.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Fabrizi
authors.affiliation: Division of Nephrology, Maggiore Hospital and IRCCS Foundation, Milano, Italy.
authors.forename: Piergiorgio
authors.initials: P
authors.lastname: Messa
authors.affiliation: Division of Hepatology, University School of Medicine, Miami, Florida.
authors.forename: Paul
authors.initials: P
authors.lastname: Martin
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D066027:Transplant Recipients
chemical_list: D000998:Antiviral Agents; D007372:Interferons